SCHEMBL5042577

SCHEMBL5042577

CCOC(C(=O)NCc1ccc(C#N)cc1Nc1ccccc1)c1ccc(OC)cc1F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR6 P46095 1/20 0.38
AKR1C3 P42330 1/20 0.37
AKR1C2 P52895 1/20 0.37
PKM P14618 1/20 0.36
MAPK1 P28482 1/20 0.36
RAB9A P51151 1/20 0.36
DGAT2 Q96PD7 2/20 0.36
EPHX2 P34913 1/20 0.35
MCHR1 Q99705 1/20 0.35
PTPN1 P18031 1/20 0.34
ACP1 P24666 2/20 0.34
PIK3CG P48736 1/20 0.34
F10 P00742 1/20 0.34
IRAK4 Q9NWZ3 1/20 0.34
HIF1A Q16665 1/20 0.34
TP53 P04637 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
MAPK8 P45983 1/20 0.33
MAPK9 P45984 1/20 0.33
MAPK10 P53779 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5046086 0.87 ALDH1A1 (0.44) GPR6MAPK1DGAT2PTPN1PIK3CG
SCHEMBL5041946 0.87 DGAT2 (0.42) DGAT2
SCHEMBL5041948 0.87 DGAT2 (0.42) DGAT2
SCHEMBL5040473 0.86 DGAT2 (0.38) GPR6DGAT2EPHX2F10MAPK8
SCHEMBL5040465 0.86 DGAT2 (0.38) GPR6DGAT2EPHX2F10MAPK8
SCHEMBL5040702 0.86 HTR2A (0.38) DGAT2F10MAPK8MAPK9MAPK10
SCHEMBL5040698 0.86 HTR2A (0.38) DGAT2F10MAPK8MAPK9MAPK10
SCHEMBL5037337 0.85 MAPK8 (0.40) DGAT2F10MAPK8MAPK9MAPK10
SCHEMBL5037335 0.85 MAPK8 (0.40) DGAT2F10MAPK8MAPK9MAPK10
SCHEMBL5041306 0.85 MAPK8 (0.42) GPR6MAPK1RAB9ADGAT2EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567498-B1 MANDELIC ACID DERIVATIVES HOFFMANN LA ROCHE (CH) 2008-01-23 EP disclosed
US-7129238-B2 Mandelic acid derivatives HOFFMANN-LA ROCHE INC. (US) 2006-10-31 US disclosed
EP-1567498-A2 MANDELIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2005-08-31 EP disclosed
US-20040122057-A1 Novel mandelic acid derivatives HOFFMANN-LA ROCHE INC. 2004-06-24 US disclosed
WO-2004048335-A2 MANDELIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2004-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040122057-A1 Novel mandelic acid derivatives F7, F11, F9 GPR6 1443/4885AKR1C3 2566/4885AKR1C2 3493/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.